Transcriptional regulation of hepatic stellate cells

Advanced Drug Delivery Reviews

Volumn 61, Issue 7-8, 2009, Pages 497-512

  Mann, Jelena ^a   Mann, Derek A ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

AP 1; Hepatic stellate cell; Liver fibrosis; NF B; Nuclear hormone receptor; SMAD; Transcription factor

Indexed keywords

AP-1; HEPATIC STELLATE CELL; LIVER FIBROSIS; NUCLEAR HORMONE RECEPTOR; SMAD;

CELL DEATH; ENDOCRINOLOGY; LIVER; TRANSCRIPTION FACTORS;

TRANSCRIPTION;

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CCAAT ENHANCER BINDING PROTEIN; CELL NUCLEUS RECEPTOR; COLLAGEN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FARNESOID X RECEPTOR; HOMEODOMAIN PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KRUPPEL LIKE FACTOR; KRUPPEL LIKE FACTOR 6; LIM PROTEIN; LIVER RECEPTOR HOMOLOG 1; MYOCYTE ENHANCER FACTOR 2; MYOD PROTEIN; NUCLEAR FACTOR I; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PREGNANE X RECEPTOR; PROTEIN C MYB; RETINOID X RECEPTOR; RETINOL; SMAD PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR ELK 1; TRANSCRIPTION FACTOR RUNX; TRANSCRIPTION FACTOR SP1;

APOPTOSIS; CELL ACTIVATION; CELL FUNCTION; CELL PROLIFERATION; CELL TRANSDIFFERENTIATION; FIBROGENESIS; GENE EXPRESSION; HUMAN; INFLAMMATION; LIVER CELL; LIVER FIBROSIS; LIVER INJURY; MOLECULAR BIOLOGY; MYOFIBROBLAST; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; STELLATE CELL; TRANSCRIPTION REGULATION; WOUND HEALING;

ANIMALS; CELL DIFFERENTIATION; GENE THERAPY; HEPATOCYTES; HUMANS; LIVER CIRRHOSIS; LIVER DISEASES; TRANSCRIPTION FACTORS;

EID: 65749103808     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2009.03.011     Document Type: Review

References (189)

1. Friedman S.L. Mechanisms of hepatic fibrogenesis. Gastroenterology 134 (2008) 1655-1669
2. Benyon R.C., and Arthur M.J. Extracellular matrix degradation and the role of hepatic stellate cells. Semin. Liver Dis. 21 3 (2001) 373-384
3. Elsharkawy A.M., Oakley F., and Mann D.A. The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Apoptosis 10 5 (2005) 927-939
4. Friedman S.L. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J. Biol. Chem. 275 4 (2000) 2247-2250
5. Iredale J.P. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J. Clin. Invest. 117 3 (2007) 539-548
6. Jones S. An overview of the basic helix-loop-helix proteins. GenomeBiology 5 6 (2004) 226
7. Massari M., and Murre C. Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol. Cell. Biol. 20 (2000) 429-440
8. Benezra R., Davis R.L., Lockshon D., Turner D.L., and Weintraub H. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 61 (1990) 49-59
9. Berkes C.A., and Tapscott S.J. MyoD and the transcriptional control of myogenesis. Semin. Cell Dev. Biol. 16 4-5 (2005) 585-595
10. Mayer D.C., and Leinwand L.A. Sarcomeric gene expression and contractility in myofibroblasts. J. Cell. Biol. 139 6 (1997) 1477-1484
11. Vincent K.J., Jones E., Arthur M.J., Smart D.E., Trim J., Wright M.C., and Mann D.A. Regulation of E-box DNA binding during in vivo and in vitro activation of rat and human hepatic stellate cells. Gut 49 5 (2001) 713-719
12. Walker G.A., Guerrero I.A., and Leinwand L.A. Myofibroblasts: molecular crossdressers. Curr. Top. Dev. Biol. 51 (2001) 91-107
13. Weintraub H., Tapscott S.J., Davis R.L., Thayer M.J., Adam M.A., Lassar A.B., and Miller A.D. Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 5434-5438
14. Wiercinska E., Wickert L., Denecke B., Said H.M., Hamzavi J., Gressner A.M., Thorikay M., ten Dijke P., Mertens P.R., Breitkopf K., and Dooley S. Id1 is a critical mediator in TGF-beta-induced transdifferentiation of rat hepatic stellate cells. Hepatology 43 5 (2006) 1032-1041
15. Tajima K., Terai S., Takami T., Kawaguchi K., Okita K., and Sakaida I. Importance of inhibitor of DNA binding/differentiation 2 in hepatic stellate cell differentiation and proliferation. Hepatol. Res. 37 8 (2007) 647-655
16. Kinoshita K., Iimuro Y., Otogawa K., Saika S., Inagaki Y., Nakajima Y., Kawada N., Fujimoto J., Friedman S.L., and Ikeda K. Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in rats. Gut 56 5 (2007) 706-714
17. Ramsay R.G. c-Myb a stem-progenitor cell regulator in multiple tissue compartments. Growth Factors 23 4 (2005) 253-261
18. Lee K.S., Buck M., Houglum K., and Chojkier M. Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression. J. Clin. Invest. 96 5 (1995) 2461-2468
19. Kitada T., Seki S., Nakatani K., Kawada N., Kuroki T., and Monna T. Hepatic expression of c-Myb in chronic human liver disease. Hepatology 26 6 (1997) 1506-1512
20. Lee K.S., Cottam H.B., Houglum K., Wasson D.B., Carson D., and Chojkier M. Pentoxifylline blocks hepatic stellate cell activation independently of phosphodiesterase inhibitory activity. Am. J. Physiol. 273 5 Pt 1 (1997) G1094-G1100
21. Buck M., Kim D.J., Houglum K., Hassanein T., and Chojkier M. c-Myb modulates transcription of the alpha-smooth muscle actin gene in activated hepatic stellate cells. Am. J. Physiol.: Gastrointest. Liver Physiol. 278 2 (2000) G321-G328
22. Ma H.H., Yao J.L., Li G., Yao C.L., Chen X.J., and Yang S.J. Effects of c-myb antisense RNA on TGF-beta1 and beta1-I collagen expression in cultured hepatic stellate cells. World J. Gastroenterol. 10 24 (2004) 3662-3665
23. Mucenski M.L., McLain K., Kier A.B., Swerdlow S.H., Schreiner C.M., Miller T.A., Pietryga D.W., Scott Jr. W.J., and Potter S.S. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 65 4 (1991) 677-689
24. Nerlov C. The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control. Trends Cell Biol. 17 7 (2007) 318-324
25. Huang G.C., Zhang J.S., and Tang Q.Q. Involvement of C/EBP-alpha gene in in vitro activation of rat hepatic stellate cells. Biochem. Biophys. Res. Commun. 324 4 (2004) 1309-1318
26. Greenwel P., Domínguez-Rosales J.A., Mavi G., Rivas-Estilla A.M., and Rojkind M. Hydrogen peroxide: a link between acetaldehyde-elicited alpha1(I) collagen gene up-regulation and oxidative stress in mouse hepatic stellate cells. Hepatology 31 1 (2000) 109-116
27. Iraburu M.J., Domínguez-Rosales J.A., Fontana L., Auster A., García-Trevijano E.R., Covarrubias-Pinedo A., Rivas-Estilla A.M., Greenwel P., and Rojkind M. Tumor necrosis factor alpha down-regulates expression of the alpha1(I) collagen gene in rat hepatic stellate cells through a p20C/EBPbeta- and C/EBPdelta-dependent mechanism. Hepatology 31 5 (2000) 1086-1093
28. Buck M., and Chojkier M. A ribosomal S-6 kinase-mediated signal to C/EBP-beta is critical for the development of liver fibrosis. PLoS ONE 2 12 (2007) e1372
29. Mei S., Wang X., Zhang J., Qian J., and Ji J. In vivo transfection of C/EBP-alpha gene could ameliorate CCL(4)-induced hepatic fibrosis in mice. Hepatol. Res. 37 7 (2007) 531-539
30. Wang N.D., Finegold M.J., Bradley A., Ou C.N., Abdelsayed S.V., Wilde M.D., Taylor L.R., Wilson D.R., and Darlington G.J. Impaired energy homeostasis in C/EBP alpha knockout mice. Science 269 5227 (1995) 1108-1112
31. García-Ruiz I., de la Torre P., Díaz T., Esteban E., Fernández I., Muñoz-Yagüe T., and Solís-Herruzo J.A. Sp1 and Sp3 transcription factors mediate malondialdehyde-induced collagen alpha 1(I) gene expression in cultured hepatic stellate cells. J. Biol. Chem. 277 34 (2002) 30551-30558
32. Inagaki Y., Nemoto T., Nakao A., Dijke P.T., Kobayashi K., Takehara K., and Greenwel P. Interaction between GC box binding factors and Smad proteins modulates cell lineage-specific alpha 2(I) collagen gene transcription. J. Biol. Chem. 276 19 (2001) 16573-16579
33. Lin S., Saxena N.K., Ding X., Stein L.L., and Anania F.A. Leptin increases tissue inhibitor of metalloproteinase I (TIMP-1) gene expression by a specificity protein 1/signal transducer and activator of transcription 3 mechanism. Mol. Endocrinol. 20 12 (2006) 3376-3388
34. Nieto N., and Cederbaum A.I. Increased Sp1-dependent transactivation of the LAMgamma 1 promoter in hepatic stellate cells co-cultured with HepG2 cells overexpressing cytochrome P450 2E1. J. Biol. Chem. 278 17 (2003) 15360-15372
35. Schnabl B., Hu K., Mühlbauer M., Hellerbrand C., Stefanovic B., Brenner D.A., and Schölmerich J. Zinc finger protein 267 is up-regulated during the activation process of human hepatic stellate cells and functions as a negative transcriptional regulator of MMP-10. Biochem. Biophys. Res. Commun. 335 1 (2005) 87-96
36. Fu Y., and Chen A. The phyto-chemical (-)-epigallocatechin gallate suppresses gene expression of epidermal growth factor receptor in rat hepatic stellate cells in vitro by reducing the activity of Egr-1. Biochem. Pharmacol. 72 2 (2006) 227-238
37. Chen A., and Zhang L. The antioxidant (-)-epigallocatechin-3-gallate inhibits rat hepatic stellate cell proliferation in vitro by blocking the tyrosine phosphorylation and reducing the gene expression of platelet-derived growth factor-beta receptor. J. Biol. Chem. 278 26 (2003) 23381-23389
38. Ratziu V., Lalazar A., Wong L., Dang Q., Collins C., Shaulian E., Jensen S., and Friedman S.L. Zf9, a Kruppel-like transcription factor up-regulated in vivo during early hepatic fibrosis. Proc. Natl. Acad. Sci. U. S. A. 95 16 (1998) 9500-9505
39. Kim Y., Ratziu V., Choi S.G., Lalazar A., Theiss G., Dang Q., Kim S.J., and Friedman S.L. Transcriptional activation of transforming growth factor beta1 and its receptors by the Kruppel-like factor Zf9/core promoter-binding protein and Sp1. Potential mechanisms for autocrine fibrogenesis in response to injury. J. Biol. Chem. 273 50 (1998) 33750-33758
40. Kojima S., Hayashi S., Shimokado K., Suzuki Y., Shimada J., Crippa M.P., and Friedman S.L. Transcriptional activation of urokinase by the Krüppel-like factor Zf9/COPEB activates latent TGF-beta1 in vascular endothelial cells. Blood 95 4 (2000) 1309-1316
41. Narla G., DiFeo A., Yao S., Banno A., Hod E., Reeves H.L., Qiao R.F., Camacho-Vanegas O., Levine A., Kirschenbaum A., Chan A.M., Friedman S.L., and Martignetti J.A. Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread. Cancer Res. 65 13 (2005) 5761-5768
42. Narla G., Difeo A., Reeves H.L., Schaid D.J., Hirshfeld J., Hod E., Katz A., Isaacs W.B., Hebbring S., Komiya A., McDonnell S.K., Wiley K.E., Jacobsen S.J., Isaacs S.D., Walsh P.C., Zheng S.L., Chang B.L., Friedrichsen D.M., Stanford J.L., Ostrander E.A., Chinnaiyan A.M., Rubin M.A., Xu J., Thibodeau S.N., Friedman S.L., and Martignetti J.A. A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk. Cancer Res. 65 4 (2005) 1213-1222
43. Miele L., Beale G., Patman G., Nobili V., Leathart J., Grieco A., Abate M., Friedman S.L., Narla G., Bugianesi E., Day C.P., and Reeves H.L. The Kruppel-like factor 6 genotype is associated with fibrosis in non-alcoholic fatty liver disease. Gastroenterology 135 1 (2008) 282-291
44. Potthoff M.J., and Olson E.N. MEF2: a central regulator of diverse developmental programs. Development 134 23 (2007) 4131-4140
45. Wang X., Tang X., Gong X., Albanis E., Friedman S.L., and Mao Z. Regulation of hepatic stellate cell activation and growth by transcription factor myocyte enhancer factor 2. Gastroenterology 127 4 (2004) 1174-1188
46. Quinn Z.A., Yang C.C., Wrana J.L., and McDermott J.C. Smad proteins function as co-modulators for MEF2 transcriptional regulatory proteins. Nucleic Acids Res. 29 3 (2001) 732-742
47. Black B.L., Molkentin J.D., and Olson E.N. Multiple roles for the MyoD basic region in transmission of transcriptional activation signals and interaction with MEF2. Mol. Cell. Biol. 18 1 (1998) 69-77
48. Park S.Y., Shin H.M., and Han T.H. Synergistic interaction of MEF2D and Sp1 in activation of the CD14 promoter. Mol. Immunol. 39 1-2 (2002) 25-30
49. Rice J.C., and Allis C.D. Histone methylation versus histone acetylation: new insights into epigenetic regulation. Curr. Opin. Cell Biol. 13 3 (2001) 263-273
50. Bai X., Wu L., Liang T., Liu Z., Li J., Li D., Xie H., Yin S., Yu J., Lin Q., and Zheng S. Overexpression of myocyte enhancer factor 2 and histone hyperacetylation in hepatocellular carcinoma. J. Cancer Res. Clin. Oncol. 134 1 (2008) 83-91
51. Houglum K., Lee K.S., and Chojkier M. Proliferation of hepatic stellate cells is inhibited by phosphorylation of CREB on serine 133. J. Clin. Invest. 99 6 (1997) 1322-1328
52. Tan Y., Lv Z.P., Bai X.C., Liu X.Y., and Zhang X.F. Traditional Chinese medicine Bao Gan Ning increase phosphorylation of CREB in liver fibrosis in vivo and in vitro. J. Ethnopharmacol. 105 1-2 (2006) 69-75
53. Zheng Q., and Zhao Y. The diverse biofunctions of LIM domain proteins: determined by subcellular localization and protein-protein interaction. Biol. Cell 99 9 (2007) 489-502
54. Kolterud A., Wandzioch E., and Carlsson L. Lhx2 is expressed in the septum transversum mesenchyme that becomes an integral part of the liver and the formation of these cells is independent of functional Lhx2. Gene Expr. Patterns 4 5 (2004) 521-528
55. Wandzioch E., Kolterud A., Jacobsson M., Friedman S.L., and Carlsson L. Lhx2-/- mice develop liver fibrosis. Proc. Natl. Acad. Sci. U. S. A. 101 47 (2004) 16549-16554
56. Chang D.F., Belaguli N.S., Iyer D., Roberts W.B., Wu S.P., Dong X.R., Marx J.G., Moore M.S., Beckerle M.C., Majesky M.W., and Schwartz R.J. Cysteine-rich LIM-only proteins CRP1 and CRP-2 are potent smooth muscle differentiation cofactors. Dev. Cell 4 1 (2003) 107-118
57. Grubinger M., and Gimona M. CRP-2 is an autonomous actin-binding protein. FEBS Lett. 557 1-3 (2004) 88-92
58. Weiskirchen R., Moser M., Weiskirchen S., Erdel M., Dahmen S., Buettner R., and Gressner A.M. LIM-domain protein cysteine- and glycine-rich protein 2 (CRP-2) is a novel marker of hepatic stellate cells and binding partner of the protein inhibitor of activated STAT1. Biochem. J. 359 Pt 3 (2001) 485-496
59. Herrmann J., Borkham-Kamphorst E., Haas U., Van de Leur E., Fraga M.F., Esteller M., Gressner A.M., and Weiskirchen R. The expression of CSRP2 encoding the LIM domain protein CRP-2 is mediated by TGF-beta in smooth muscle and hepatic stellate cells. Biochem. Biophys. Res. Commun. 345 4 (2006) 1526-1535
60. Herrmann J., Arias M., Van De Leur E., Gressner A.M., and Weiskirchen R. CSRP2, TIMP-1, and SM22alpha promoter fragments direct hepatic stellate cell-specific transgene expression in vitro, but not in vivo. Liver Int. 24 1 (2004) 69-79
61. Bahr M.J., Vincent K.J., Arthur M.J., Fowler A.V., Smart D.E., Wright M.C., Clark I.M., Benyon R.C., Iredale J.P., and Mann D.A. Control of the tissue inhibitor of metalloproteinases-1 promoter in culture-activated rat hepatic stellate cells: regulation by activator protein-1 DNA binding proteins. Hepatology 29 3 (1999) 839-848
62. Clark I.M., Rowan A.D., Edwards D.R., Bech-Hansen T., Mann D.A., Bahr M.J., and Cawston T.E. Transcriptional activity of the human tissue inhibitor of metalloproteinases 1 (TIMP-1) gene in fibroblasts involves elements in the promoter, exon 1 and intron 1. Biochem. J. 324 Pt 2 (1997) 611-617
63. Bertrand-Philippe M., Ruddell R.G., Arthur M.J., Thomas J., Mungalsingh N., and Mann D.A. Regulation of tissue inhibitor of metalloproteinase 1 gene transcription by RUNX1 and RUNX. J. Biol. Chem. 279 23 (2004) 24530-24539
64. Smart D.E., Vincent K.J., Arthur M.J., Eickelberg O., Castellazzi M., Mann J., and Mann D.A. JunD regulates transcription of the tissue inhibitor of metalloproteinases-1 and interleukin-6 genes in activated hepatic stellate cells. J. Biol. Chem. 276 26 (2001) 24414-24421
65. Park E.Y., Shin S.M., Ma C.J., Kim Y.C., and Kim S.G. Meso-dihydroguaiaretic acid from Machilus thunbergii down-regulates TGF-beta1 gene expression in activated hepatic stellate cells via inhibition of AP-1 activity. Planta Med. 71 5 (2005) 393-398
66. Smart D.E., Green K., Oakley F., Weitzman J.B., Yaniv M., Reynolds G., Mann J., Millward-Sadler H., and Mann D.A. JunD is a profibrogenic transcription factor regulated by Jun N-terminal kinase-independent phosphorylation. Hepatology 44 6 (2006) 1432-1440
67. Li J., Hu W., Baldassare J.J., Bora P.S., Chen S., Poulos J.E., O'Neill R., Britton R.S., and Bacon B.R. The ethanol metabolite, linolenic acid ethyl ester, stimulates mitogen-activated protein kinase and cyclin signaling in hepatic stellate cells. Life Sci. 73 9 (2003) 1083-1096
68. Li W., Zhang J., Huang Q., Zhu H., and Zhang X. Long-term administering low anticoagulant activity heparin can lessen rat hepatic fibrosis induced by either CCl(4) or porcine serum injection. Hepatol. Res. 36 2 (2006) 115-123
69. Liu X.J., Yang L., Mao Y.Q., Wang Q., Huang M.H., Wang Y.P., and Wu H.B. Effects of the tyrosine protein kinase inhibitor genistein on the proliferation, activation of cultured rat hepatic stellate cells. World J. Gastroenterol. 8 4 (2002) 739-745
70. Chen Y.X., Zhang X.R., Xie W.F., and Li S. Effects of taurine on proliferation and apoptosis of hepatic stellate cells in vitro. Hepatobiliary Pancreat. Dis. Int. 3 1 (2004) 106-109
71. Saxena N.K., Saliba G., Floyd J.J., and Anania F.A. Leptin induces increased alpha2(I) collagen gene expression in cultured rat hepatic stellate cells. J. Cell. Biochem. 89 2 (2003) 311-320
72. Gui M., Zhang Y.F., Xiao Z.Y., Sun P., Dai J.F., Wang S.F., Rui Y.C., and Zhang J.P. Inhibitory effect of emodin on tissue inhibitor of metalloproteinases-1 (TIMP-1) expression in rat hepatic stellate cells. Dig. Dis. Sci. 52 1 (2007) 200-207
73. Lee S.H., Seo G.S., Kim H.S., Woo S.W., Ko G., and Sohn D.H. 2′,4′,6′-Tris(methoxymethoxy) chalcone attenuates hepatic stellate cell proliferation by a heme oxygenase-dependent pathway. Biochem. Pharmacol. 72 10 (2006) 1322-1333
74. Trim J.E., Samra S.K., Arthur M.J., Wright M.C., McAulay M., Beri R., and Mann D.A. Upstream tissue inhibitor of metalloproteinases-1 (TIMP-1) element-1, a novel and essential regulatory DNA motif in the human TIMP-1 gene promoter, directly interacts with a 30-kDa nuclear protein. J. Biol. Chem. 275 9 (2000) 6657-6663
75. Gehring W.J. Homeo boxes in the study of development. Science 236 (1987) 1245-1252
76. Jiang F., and Stefanovic B. Homeobox gene Prx1 is expressed in activated hepatic stellate cells and transactivates collagen alpha1(I) promoter. Exp. Biol. Medicine (Maywood) 233 3 (2008) 286-296
77. Fritz D., and Stefanovic B. RNA-binding protein RBMS3 is expressed in activated hepatic stellate cells and liver fibrosis and increases expression of transcription factor Prx1. J. Mol. Biol. 371 3 (2007) 585-595
78. Macleod K., Leprince D., and Stehelin D. The ETS gene family. Trends Biochem. Sci. 17 7 (1992) 251-256
79. Sharrocks A.D. The ETS-domain transcription factor family. Nat. Rev. Mol. Cell Biol. 2 11 (2001) 827-837
80. Borden P., and Heller R.A. Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases. Crit. Rev. Eukaryot. Gene Expr. 7 1-2 (1997) 159-178
81. Knittel T., Kobold D., Dudas J., Saile B., and Ramadori G. Role of the Ets-1 transcription factor during activation of rat hepatic stellate cells in culture. Am. J. Pathol. 155 6 (1999) 1841-1848
82. Ozaki I., Zhao G., Mizuta T., Ogawa Y., Hara T., Kajihara S., Hisatomi A., Sakai T., and Yamamoto K. Hepatocyte growth factor induces collagenase (matrix metalloproteinase-1) via the transcription factor Ets-1 in human hepatic stellate cell line. J. Hepatol. 36 2 (2002) 169-178
83. Znoyko I., Trojanowska M., and Reuben A. Collagen binding alpha2beta1 and alpha1beta1 integrins play contrasting roles in regulation of Ets-1 expression in human liver myofibroblasts. Mol. Cell. Biochem. 282 1-2 (2006) 89-99
84. Leask A., Chen S., Pala D., and Brigstock D.R. Regulation of CCN2 mRNA expression and promoter activity in activated hepatic stellate cells. J. Cell. Commun. Signal. 2 1-2 (2008) 49-56
85. Eckert D., Buhl S., Weber S., Jäger R., and Schorle H. The AP-2 family of transcription factors. GenomeBiology 6 13 (2005) 246
86. Chen A., Beno D.W., and Davis B.H. Suppression of stellate cell type I collagen gene expression involves AP-2 transmodulation of nuclear factor-1-dependent gene transcription. J. Biol. Chem. 271 42 (1996) 25994-25998
87. Miao K., Potter J.J., Anania F.A., Rennie-Tankersley L., and Mezey E. Identification of two repressor elements in the mouse alpha 2(I) collagen promoter. Arch. Biochem. Biophys. 361 1 (1999) 7-16
88. Mazzocca A., Sciammetta S.C., Carloni V., Cosmi L., Annunziato F., Harada T., Abrignani S., and Pinzani M. Binding of hepatitis C virus envelope protein E2 to CD81 up-regulates matrix metalloproteinase-2 in human hepatic stellate cells. J. Biol. Chem. 280 12 (2005) 11329-11339
89. Gronostajski R.M. Role of NFI/CTF gene family in transcription and development. Gene 249 (2000) 31-45
90. Anania F.A., Potter J.J., Rennie-Tankersley L., and Mezey E. Effects of acetaldehyde on nuclear protein binding to the nuclear factor I consensus sequence in the alpha 2(I) collagen promoter. Hepatology 21 6 (1995) 1640-1648
91. Anania F.A., Potter J.J., Rennie-Tankersley L., and Mezey E. Activation by acetaldehyde of the promoter of the mouse alpha2(I) collagen gene when transfected into rat activated stellate cells. Arch. Biochem. Biophys. 331 2 (1996) 187-193
92. Miao K., Potter J.J., Anania F.A., Rennie-Tankersley L., and Mezey E. Effect of acetaldehyde on Sp1 binding and activation of the mouse alpha 2(I) collagen promoter. Arch. Biochem. Biophys. 341 1 (1997) 140-152
93. Yavrom S., Chen L., Xiong S., Wang J., Rippe R.A., and Tsukamoto H. Peroxisome proliferator-activated receptor gamma suppresses proximal alpha1(I) collagen promoter via inhibition of p300-facilitated NF-I binding to DNA in hepatic stellate cells. J. Biol. Chem. 280 49 (2005) 40650-40659
94. Ribeiro R.C., Kushner P.J., and Baxter J.D. The nuclear hormone receptor gene superfamily. Annu. Rev. Med. 46 (1995) 443-453
95. Rastinejad F. Retinoid X receptor and its partners in the nuclear receptor family. Curr. Opin. Struct. Biol. 11 1 (2001) 33-38
96. Milliano M.T., and Luxon B.A. Rat hepatic stellate cells become retinoid unresponsive during activation. Hepatol. Res. 33 3 (2005) 225-233
97. Mezaki Y., Yoshikawa K., Yamaguchi N., Miura M., Imai K., Kato S., and Senoo H. Rat hepatic stellate cells acquire retinoid responsiveness after activation in vitro by post-transcriptional regulation of retinoic acid receptor alpha gene expression. Arch. Biochem. Biophys. 465 2 (2007) 370-379
98. Hellemans K., Verbuyst P., Quartier E., Schuit F., Rombouts K., Chandraratna R.A., Schuppan D., and Geerts A. Differential modulation of rat hepatic stellate phenotype by natural and synthetic retinoids. Hepatology 39 1 (2004) 97-108
99. Okuno M., Sato T., Kitamoto T., Imai S., Kawada N., Suzuki Y., Yoshimura H., Moriwaki H., Onuki K., Masushige S., Muto Y., Friedman S.L., Kato S., and Kojima S. Increased 9,13-di-cis-retinoic acid in rat hepatic fibrosis: implication for a potential link between retinoid loss and TGF-beta mediated fibrogenesis in vivo. J. Hepatol. 30 6 (1999) 1073-1080
100. Chen C., Zhang J., Li J., Huang J., Yang C., Huang G., and Shi J. Hydrodynamic-based in vivo transfection of retinoic X receptor-alpha gene can enhance vitamin A-induced attenuation of liver fibrosis in mice. Liver Int. 24 6 (2004) 679-686
101. Kuipers F., Claudel T., Sturm E., and Staels B. The Farnesoid X Receptor (FXR) as modulator of bile acid metabolism. Rev. Endocr. Metab. Disord. 5 4 (2004) 319-326
102. Fiorucci S., Rizzo G., Donini A., Distrutti E., and Santucci L. Targeting farnesoid X receptor for liver and metabolic disorders. Trends Mol. Med. 13 7 (2007) 298-309
103. Goodwin B., Jones S.A., Price R.R., Watson M.A., McKee D.D., Moore L.B., Galardi C., Wilson J.G., Lewis M.C., Roth M.E., Maloney P.R., Willson T.M., and Kliewer S.A. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol. Cell 6 3 (2000) 517-526
104. Lu T.T., Makishima M., Repa J.J., Schoonjans K., Kerr T.A., Auwerx J., and Mangelsdorf D.J. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol. Cell 6 3 (2000) 507-515
105. Chen W., Owsley E., Yang Y., Stroup D., and Chiang J.Y. Nuclear receptor-mediated repression of human cholesterol 7alpha-hydroxylase gene transcription by bile acids. J. Lipid Res. 42 9 (2001) 1402-1412
106. Fiorucci S., Antonelli E., Rizzo G., Renga B., Mencarelli A., Riccardi L., Orlandi S., Pellicciari R., and Morelli A. The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis. Gastroenterology 127 5 (2004) 1497-1512
107. Fiorucci S., Rizzo G., Antonelli E., Renga B., Mencarelli A., Riccardi L., Orlandi S., Pruzanski M., Morelli A., and Pellicciari R. A farnesoid x receptor-small heterodimer partner regulatory cascade modulates tissue metalloproteinase inhibitor-1 and matrix metalloprotease expression in hepatic stellate cells and promotes resolution of liver fibrosis. J. Pharmacol. Exp. Ther. 314 2 (2005) 584-595
108. Fiorucci S., Rizzo G., Antonelli E., Renga B., Mencarelli A., Riccardi L., Morelli A., Pruzanski M., and Pellicciari R. Cross-talk between farnesoid-X-receptor (FXR) and peroxisome proliferator-activated receptor gamma contributes to the antifibrotic activity of FXR ligands in rodent models of liver cirrhosis. J. Pharmacol. Exp. Ther. 315 1 (2005) 58-68
109. Lee J.H., Zhou J., and Xie W. PXR and LXR in hepatic steatosis: a new dog and an old dog with new tricks. Mol. Pharm. 5 1 (2008) 60-66
110. Timsit Y.E., and Negishi M. CAR and PXR: the xenobiotic-sensing receptors. Steroids 72 3 (2007) 231-246
111. Wright M.C. The impact of pregnane X receptor activation on liver fibrosis. Biochem. Soc. Trans. 34 Pt 6 (2006) 1119-1123
112. Guo G.L., Lambert G., Negishi M., Ward J.M., Brewer Jr. H.B., Kliewer S.A., Gonzalez F.J., and Sinal C.J. Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity. J. Biol. Chem. 278 46 (2003) 45062-45071
113. Haughton E.L., Tucker S.J., Marek C.J., Durward E., Leel V., Bascal Z., Monaghan T., Koruth M., Collie-Duguid E., Mann D.A., Trim J.E., and Wright M.C. Pregnane X receptor activators inhibit human hepatic stellate cell transdifferentiation in vitro. Gastroenterology 131 1 (2006) 194-209
114. Marek C.J., Tucker S.J., Konstantinou D.K., Elrick L.J., Haefner D., Sigalas C., Murray G.I., Goodwin B., and Wright M.C. Pregnenolone-16alpha-carbonitrile inhibits rodent liver fibrogenesis via PXR (pregnane X receptor)-dependent and PXR-independent mechanisms. Biochem. J. 387 Pt 3 (2005) 601-608
115. Kota B.P., Huang T.H., and Roufogalis B.D. An overview on biological mechanisms of PPARs. Pharmacol. Res. 51 2 (2005) 85-94
116. Hazra S., Miyahara T., Rippe R.A., and Tsukamoto H. PPAR gamma and hepatic stellate cells. Comp. Hepatol. 3 Suppl 1 (2004) S7
117. Sato T., Sato M., Miura M., Higashi N., Wang D.R., Suzuki S., Imai K., Kojima N., and Senoo H. Expression of the peroxisome proliferator-activated receptors (PPARs) in the hepatic stellate cells. Comp. Hepatol. 3 Suppl 1 (2004) S17
118. Miyahara T., Schrum L., Rippe R., Xiong S., Yee Jr. H.F., Motomura K., Anania F.A., Willson T.M., and Tsukamoto H. Peroxisome proliferator-activated receptors and hepatic stellate cell activation. J. Biol. Chem. 275 46 (2000) 35715-35722
119. Ziouzenkova O., and Plutzky J. Retinoid metabolism and nuclear receptor responses: New insights into coordinated regulation of the PPAR-RXR complex. FEBS Lett. 582 1 (2008) 32-38
120. Tsukamoto H., She H., Hazra S., Cheng J., and Miyahara T. Anti-adipogenic regulation underlies hepatic stellate cell transdifferentiation. J. Gastroenterol. Hepatol. 21 Suppl 3 (2006) S102-105
121. She H., Xiong S., Hazra S., and Tsukamoto H. Adipogenic transcriptional regulation of hepatic stellate cells. J. Biol. Chem. 280 6 (2005) 4959-4967
122. Hazra S., Xiong S., Wang J., Rippe R.A., Krishna V., Chatterjee K., and Tsukamoto H. Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells. J. Biol. Chem. 279 12 (2004) 11392-11401
123. Zhao C., Chen W., Yang L., Chen L., Stimpson S.A., and Diehl A.M. PPARgamma agonists prevent TGFbeta1/Smad3-signaling in human hepatic stellate cells. Biochem. Biophys. Res. Commun. 350 2 (2006) 385-391
124. Sun K., Wang Q., and Huang X.H. PPAR gamma inhibits growth of rat hepatic stellate cells and TGF beta-induced connective tissue growth factor expression. Acta Pharmacol. Sin. 27 6 (2006) 715-723
125. Zheng S., and Chen A. Disruption of transforming growth factor-beta signaling by curcumin induces gene expression of peroxisome proliferator-activated receptor-gamma in rat hepatic stellate cells. Am. J. Physiol.: Gastrointest. Liver Physiol. 292 1 (2007) G113-G123
126. Cheng Y., Ping J., and Xu L.M. Effects of curcumin on peroxisome proliferator-activated receptor gamma expression and nuclear translocation/redistribution in culture-activated rat hepatic stellate cells. Chin. Med. J. (Engl) 120 9 (2007) 794-801
127. Xu J., Fu Y., and Chen A. Activation of peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth. Am. J. Physiol.: Gastrointest. Liver Physiol. 285 1 (2003) G20-G30
128. Zheng S., and Chen A. Curcumin suppresses the expression of extracellular matrix genes in activated hepatic stellate cells by inhibiting gene expression of connective tissue growth factor. Am. J. Physiol.: Gastrointest. Liver Physiol. 290 5 (2006) G883-G893
129. Fu Y., Zheng S., Lin J., Ryerse J., and Chen A. Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation. Mol. Pharmacol. 73 2 (2008) 399-409
130. Guimarães E.L., Franceschi M.F., Andrade C.M., Guaragna R.M., Borojevic R., Margis R., Bernard E.A., and Guma F.C. Hepatic stellate cell line modulates lipogenic transcription factors. Liver Int. 27 9 (2007) 1255-1264
131. Planagumà A., Clària J., Miquel R., López-Parra M., Titos E., Masferrer J.L., Arroyo V., and Rodés J. The selective cyclooxygenase-2 inhibitor SC-236 reduces liver fibrosis by mechanisms involving non-parenchymal cell apoptosis and PPARgamma activation. FASEB J. 19 9 (2005) 1120-1122
132. Sung C.K., She H., Xiong S., and Tsukamoto H. Tumor necrosis factor-alpha inhibits peroxisome proliferator-activated receptor gamma activity at a posttranslational level in hepatic stellate cells. Am. J. Physiol.: Gastrointest. Liver Physiol. 286 5 (2004) G722-G729
133. Kawaguchi K., Sakaida I., Tsuchiya M., Omori K., Takami T., and Okita K. Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet. Biochem. Biophys. Res. Commun. 315 1 (2004) 187-195
134. Kon K., Ikejima K., Hirose M., Yoshikawa M., Enomoto N., Kitamura T., Takei Y., and Sato N. Pioglitazone prevents early-phase hepatic fibrogenesis caused by carbon tetrachloride. Biochem. Biophys. Res. Commun. 291 1 (2002) 55-61
135. Lee J.I., Paik Y.H., Lee K.S., Lee J.W., Kim Y.S., Jeong S., Kwon K.S., Lee D.H., Kim H.G., Shin Y.W., and Kim M.A. A peroxisome-proliferator activated receptor-gamma ligand could regulate the expression of leptin receptor on human hepatic stellate cells. Histochem. Cell Biol. 127 5 (2007) 495-502
136. Bruck R., Weiss S., Aeed H., Pines M., Halpern Z., and Zvibel I. Additive inhibitory effect of experimentally induced hepatic cirrhosis by agonists of peroxisome proliferator activator receptor gamma and retinoic acid receptor. Dig. Dis. Sci. 54 2 (2009) 292-299
137. Hellemans K., Michalik L., Dittie A., Knorr A., Rombouts K., De Jong J., Heirman C., Quartier E., Schuit F., Wahli W., and Geerts A. Peroxisome proliferator-activated receptor-beta signaling contributes to enhanced proliferation of hepatic stellate cells. Gastroenterology 124 1 (2003) 184-201
138. Shan W., Palkar P.S., Murray I.A., McDevitt E.I., Kennett M.J., Kang B.H., Isom H.C., Perdew G.H., Gonzalez F.J., and Peters J.M. Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression. Toxicol. Sci. 105 2 (2008) 418-428
139. Hellemans K., Rombouts K., Quartier E., Dittié A.S., Knorr A., Michalik L., Rogiers V., Schuit F., Wahli W., and Geerts A. PPARbeta regulates vitamin A metabolism-related gene expression in hepatic stellate cells undergoing activation. J. Lipid Res. 44 2 (2003) 280-295
140. Shimizu I., Mizobuchi Y., Yasuda M., Shiba M., Ma Y.R., Horie T., Liu F., and Ito S. Inhibitory effect of oestradiol on activation of rat hepatic stellate cells in vivo and in vitro. Gut 44 1 (1999) 127-136
141. Shimizu I., and Ito S. Protection of estrogens against the progression of chronic liver disease. Hepatol. Res. 37 4 (2007) 239-247
142. Theodoropoulos C., Demers C., Petit J.L., and Gascon-Barre M. High sensitivity of rat hepatic vitamin D3-25 hydroxylase CYP27A to 1,25-dihydroxyvitamin D3 administration. Am. J. Physiol., Endocrinol Metabol. 284 1 (2003) E138-147
143. Raddatz D., Henneken M., Armbrust T., and Ramadori G. Subcellular distribution of glucocorticoid receptor in cultured rat and human liver-derived cells and cell lines: influence of dexamethasone. Hepatology 24 4 (1996) 928-933
144. Schmierer B., and Hill C.S. TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility. Nat. Rev. Mol. Cell Biol. 8 12 (2007) 970-982
145. Hayashi H., Abdollah S., Qiu Y., Cai J., Xu Y.Y., Grinnell B.W., Richardson M.A., Topper J.N., Gimbrone Jr. M.A., Wrana J.L., and Falb D. The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signalling. Cell 89 7 (1997) 1165-1173
146. Liu C., Gaça M.D., Swenson E.S., Vellucci V.F., Reiss M., and Wells R.G. Smads 2 and 3 are differentially activated by transforming growth factor-beta (TGF-beta) in quiescent and activated hepatic stellate cells. Constitutive nuclear localization of Smads in activated cells is TGF-beta-independent. J. Biol. Chem. 278 13 (2003) 11721-11728
147. Dooley S., Streckert M., Delvoux B., and Gressner A.M. Expression of Smads during in vitro transdifferentiation of hepatic stellate cells to myofibroblasts. Biochem. Biophys. Res. Commun. 283 3 (2001) 554-562
148. Tahashi Y., Matsuzaki K., Date M., Yoshida K., Furukawa F., Sugano Y., Matsushita M., Himeno Y., Inagaki Y., and Inoue K. Differential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injury. Hepatology 35 1 (2002) 49-61
149. Seyhan H., Hamzavi J., Wiercinska E., Gressner A.M., Mertens P.R., Kopp J., Horch R.E., Breitkopf K., and Dooley S. Liver fibrogenesis due to cholestasis is associated with increased Smad7 expression and Smad3 signaling. J. Cell. Mol. Med. 10 4 (2006) 922-932
150. Liu Y., Wang L.F., Zou H.F., Song X.Y., Xu H.F., Lin P., Zheng H.H., and Yu X.G. Expression and location of Smad2, 4 mRNAs during and after liver fibrogenesis of rats. World J. Gastroenterol. 12 10 (2006) 1577-11582
151. Weng H., Mertens P.R., Gressner A.M., and Dooley S. IFN-gamma abrogates profibrogenic TGF-beta signaling in liver by targeting expression of inhibitory and receptor Smads. J. Hepatol. 46 2 (2007) 295-303
152. Inagaki Y., Nemoto T., Kushida M., Sheng Y., Higashi K., Ikeda K., Kawada N., Shirasaki F., Takehara K., Sugiyama K., Fujii M., Yamauchi H., Nakao A., de Crombrugghe B., Watanabe T., and Okazaki I. Interferon alfa down-regulates collagen gene transcription and suppresses experimental hepatic fibrosis in mice. Hepatology 38 4 (2003) 890-899
153. Kamada Y., Tamura S., Kiso S., Fukui K., Doi Y., Ito N., Terui Y., Saito T., Watanabe H., Togashi H., Kawata S., and Matsuzawa Y. Angiotensin II stimulates the nuclear translocation of Smad2 and induces PAI-1 mRNA in rat hepatic stellate cells. Hepatol. Res. 25 3 (2003) 296-305
154. Liu X., Wang W., Hu H., Tang N., Zhang C., Liang W., and Wang M. Smad3 specific inhibitor, naringenin, decreases the expression of extracellular matrix induced by TGF-beta1 in cultured rat hepatic stellate cells. Pharm. Res. 23 1 (2006) 82-89
155. Inagaki Y., Higashi K., Kushida M., Hong Y.Y., Nakao S., Higashiyama R., Moro T., Itoh J., Mikami T., Kimura T., Shiota G., Kuwabara I., and Okazaki I. Hepatocyte growth factor suppresses profibrogenic signal transduction via nuclear export of Smad3 with galectin-7. Gastroenterology 134 4 (2008) 1180-1190
156. Schnabl B., Kweon Y.O., Frederick J.P., Wang X.F., Rippe R.A., and Brenner D.A. The role of Smad3 in mediating mouse hepatic stellate cell activation. Hepatology 34 1 (2001) 89-100
157. Dooley S., Hamzavi J., Breitkopf K., Wiercinska E., Said H.M., Lorenzen J., Ten Dijke P., and Gressner A.M. Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology 125 1 (2003) 178-191
158. Fan J., Shen H., Sun Y., Li P., Burczynski F., Namaka M., and Gong Y. Bone morphogenetic protein 4 mediates bile duct ligation induced liver fibrosis through activation of Smad1 and ERK1/2 in rat hepatic stellate cells. J. Cell. Physiol. 207 2 (2006) 499-505
159. Elsharkawy A.M., and Mann D.A. Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis. Hepatology 46 2 (2007) 590-597
160. Oakley F., Mann J., Nailard S., Smart D.E., Mungalsingh N., Constandinou C., Ali S., Wilson S.J., Millward-Sadler H., Iredale J.P., and Mann D.A. Nuclear factor-kappaB1 (p50) limits the inflammatory and fibrogenic responses to chronic injury. Am. J. Pathol. 166 3 (2005) 695-708
161. Rupec R.A., Poujol D., Grosgeorge J., Carle G.F., Livolsi A., Peyron J.F., Schmid R.M., Baeuerle P.A., and Messer G. Structural analysis, expression, and chromosomal localization of the mouse IkBa gene. Immunogenetics 49 5 (1999) 395-403
162. Hay R.T., Vuillard L., Desterro J.M., and Rodriguez M.S. Control of NF-kappa B transcriptional activation by signal induced proteolysis of I kappa B alpha. Philos. Trans. R. Soc. Lond., B Biol. Sci. 354 1389 (1999) 1601-1609
163. Rodriguez M.S., Thompson J., Hay R.T., and Dargemont C. Nuclear retention of IkappaBalpha protects it from signal-induced degradation and inhibits nuclear factor kappaB transcriptional activation. J. Biol. Chem. 274 13 (1999) 9108-9115
164. Tergaonkar V. NFkappaB pathway: a good signaling paradigm and therapeutic target. Int. J. Biochem. Cell Biol. 38 10 (2006) 1647-1653
165. Elsharkawy A.M., Oakley F., and Mann D.A. The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Apoptosis 10 5 (2005) 927-939
166. Oakley F., Mann J., Ruddell R.G., Pickford J., Weinmaster G., and Mann D.A. Basal expression of IkappaBalpha is controlled by the mammalian transcriptional repressor RBP-J (CBF1) and its activator Notch1. J. Biol. Chem. 278 27 (2003) 24359-24370
167. Mann J., Oakley F., Akiboye F., Elsharkawy A., Thorne A.W., and Mann D.A. Regulation of myofibroblast transdifferentiation by DNA methylation and MeCP2: implications for wound healing and fibrogenesis. Cell Death Differ. 14 2 (2007) 275-285
168. Hellerbrand C., Jobin C., Iimuro Y., Licato L., Sartor R.B., and Brenner D.A. Inhibition of NFkappaB in activated rat hepatic stellate cells by proteasome inhibitors and an IkappaB super-repressor. Hepatology 27 5 (1998) 1285-1295
169. Douglass A., Wallace K., Parr R., Park J., Durward E., Broadbent I., Barelle C., Porter A.J., and Wright M.C. Antibody-targeted myofibroblast apoptosis reduces fibrosis during sustained liver injury. J. Hepatol. 49 1 (2008) 88-98
170. Watson M.R., Wallace K., Gieling R.G., Manas D.M., Jaffray E., Hay R.T., Mann D.A., and Oakley F. NF-kappaB is a critical regulator of the survival of rodent and human hepatic myofibroblasts. J. Hepatol. 48 4 (2008) 589-597
171. Oakley F., Meso M., Iredale J.P., Green K., Marek C.J., Zhou X., May M.J., Millward-Sadler H., Wright M.C., and Mann D.A. Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis. Gastroenterology 128 1 (2005) 108-120
172. Son G., Iimuro Y., Seki E., Hirano T., Kaneda Y., and Fujimoto J. Selective inactivation of NF-kappaB in the liver using NF-kappaB decoy suppresses CCl4-induced liver injury and fibrosis. Am. J. Physiol.: Gastrointest. Liver Physiol. 293 3 (2007) G631-G639
173. Chong L.W., Hsu Y.C., Chiu Y.T., Yang K.C., and Huang Y.T. Anti-fibrotic effects of thalidomide on hepatic stellate cells and dimethylnitrosamine-intoxicated rats. J. Biomed. Sci. 13 3 (2006) 403-418
174. Hsu Y.C., Chiu Y.T., Cheng C.C., Wu C.F., Lin Y.L., and Huang Y.T. Antifibrotic effects of tetrandrine on hepatic stellate cells and rats with liver fibrosis. J. Gastroenterol. Hepatol. 22 1 (2007) 99-111
175. Zhang L.J., Zheng W.D., Shi M.N., and Wang X.Z. Effects of interleukin-10 on activation and apoptosis of hepatic stellate cells in fibrotic rat liver. World J. Gastroenterol. 12 12 (2006) 1918-1923
176. Popov Y., Patsenker E., Bauer M., Niedobitek E., Schulze-Krebs A., and Schuppan D. Halofuginone induces matrix metalloproteinases in rat hepatic stellate cells via activation of p38 and NFkappaB. J. Biol. Chem. 281 22 (2006) 15090-15098
177. Novitskiy G., Ravi R., Potter J.J., Rennie-Tankersley L., Wang L., and Mezey E. Effects of acetaldehyde and TNF alpha on the inhibitory kappa B-alpha protein and nuclear factor kappa B activation in hepatic stellate cells. Alcohol Alcohol. 40 2 (2005) 96-101
178. Novitskiy G., Traore K., Wang L., Trush M.A., and Mezey E. Effects of ethanol and acetaldehyde on reactive oxygen species production in rat hepatic stellate cells. Alcohol Clin. Exp. Res. 30 8 (2006) 1429-1435
179. Hernández E., Bucio L., Souza V., Escobar M.C., Gómez-Quiroz L.E., Farfán B., Kershenobich D., and Gutiérrez-Ruiz M.C. Pentoxifylline downregulates alpha (I) collagen expression by the inhibition of Ikappabalpha degradation in liver stellate cells. Cell Biol. Toxicol. 24 4 (2008) 303-314
180. Seki E., De Minicis S., Osterreicher C.H., Kluwe J., Osawa Y., Brenner D.A., and Schwabe R.F. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat. Med. 13 11 (2007) 1324-1332
181. Paik Y.H., Schwabe R.F., Bataller R., Russo M.P., Jobin C., and Brenner D.A. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology 37 5 (2003) 1043-1055
182. Thirunavukkarasu C., Watkins S.C., and Gandhi C.R. Mechanisms of endotoxin-induced NO, IL-6, and TNF-alpha production in activated rat hepatic stellate cells: role of p38 MAPK. Hepatology 44 2 (2006) 389-398
183. Schwabe R.F., Schnabl B., Kweon Y.O., and Brenner D.A. CD40 activates NF-kappa B and c-Jun N-terminal kinase and enhances chemokine secretion on activated human hepatic stellate cells. J. Immunol. 166 11 (2001) 6812-6819
184. Lang A., Schoonhoven R., Tuvia S., Brenner D.A., and Rippe R.A. Nuclear factor kappaB in proliferation, activation, and apoptosis in rat hepatic stellate cells. J. Hepatol. 33 1 (2000) 49-58
185. Anan A., Baskin-Bey E.S., Bronk S.F., Werneburg N.W., Shah V.H., and Gores G.J. Proteasome inhibition induces hepatic stellate cell apoptosis. Hepatology 43 2 (2006) 335-344
186. Bell D.M., Leung K.K., Wheatley S.C., Ng L.J., Zhou S., Ling K.W., Sham M.H., Koopman P., Tam P.P., and Cheah K.S. SOX9 directly regulates the type-II collagen gene. Nat. Genet. 16 2 (1997) 174-178
187. Hanley K.P., Oakley F., Sugden S., Wilson D.I., Mann D.A., and Hanley N.A. Ectopic SOX9 mediates extracellular matrix deposition characteristic of organ fibrosis. J. Biol. Chem. 283 20 (2008) 14063-14071
188. Podesta A., Lopez P., Terg R., Villamil F., Flores D., Mastai R., Udaondo C.B., and Companc J.P. Treatment of pruritus of primary biliary cirrhosis with rifampin. Dig. Dis. Sci. 36 2 (1991) 216-220
189. Khurana S., and Singh P. Rifampin is safe for treatment of pruritus due to chronic cholestasis: a meta-analysis of prospective randomized-controlled trials. Liver Int. 26 8 (2006) 943-948